earnings
Commercial Pivot Stabilizes Biogen: Growth Products Lead Recovery (BIIB Q1 2026 Earnings Call)
Biogen Inc. stabilized its first-quarter financial performance as its growth portfolio offset legacy franchise declines, marking a positive commercial shift.